MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent

Nature Communications

Volumn 6, Issue , 2015, Pages

  Zhou, Zhuxian ^a,b   Qutaish, Mohammed ^a   Han, Zheng ^a   Schur, Rebecca M ^a   Liu, Yiqiao ^a   Wilson, David L ^a,c   Lu, Zheng Rong ^a  

^a Case Western Reserve University   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,7,10 TRIS(CARBOXYMETHYL) 1,4,7,10 TETRAAZACYCLODODECYL GADOLINIUM; FIBRIN; FIBRONECTIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; CONTRAST MEDIUM; COORDINATION COMPOUND; CREKA-TRIS(GD-DOTA)3; OLIGOPEPTIDE;

CANCER; CRYOBIOLOGY; DETECTION METHOD; DISEASE INCIDENCE; FLUORESCENCE SPECTROSCOPY; HEALTH RISK; IMAGE RESOLUTION; IMAGING METHOD; MOLECULAR ANALYSIS; PROTEIN; RODENT; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BODY IMAGE; BREAST METASTASIS; CANCER CELL; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG PROTEIN BINDING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; IMAGE ANALYSIS; LIMIT OF DETECTION; MICROMETASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTEIN EXPRESSION; ANIMAL; CHEMISTRY; EXPERIMENTAL MAMMARY NEOPLASM; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; NUDE MOUSE; PATHOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

MUS;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; COORDINATION COMPLEXES; FEMALE; FIBRONECTINS; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES; TISSUE DISTRIBUTION;

EID: 84939211888     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8984     Document Type: Article

References (53)

1. Chaffer, C. L. &Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564 (2011).
2. Weigelt, B., Peterse, J. L. & van't Veer, L. J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591-602 (2005).
3. Lu, J. et al. Breast cancer metastasis: challenges and opportunities. Cancer Res. 69, 4951-4953 (2009).
4. Lee, C. H. et al. Breast cancer screening with imaging: recommendations from the society of breast imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J. Am. Coll. Radiol. 7, 18-27 (2010).
5. Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449-458 (2006).
6. Zhou, Z. & Lu, Z. R. Gadolinium-based contrast agents for magnetic resonance cancer imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5, 1-18 (2013).
7. Caravan, P., Ellison, J. J., McMurry, T. J. & Lauffer, R. B. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352 (1999).
8. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437 (2013).
9. Reticker-Flynn, N. E. et al. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat. Commun. 3, 1122 (2012).
10. Lu, P. F., Weaver, V. M. & Werb, Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196, 395-406 (2012).
11. Malik, G. et al. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res. 70, 4327-4334 (2010).
12. Clark, E. A., Golub, T. R., Lander, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000).
13. Yao, E. S. et al. Increased b1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 67, 659-664 (2007).
14. Rybak, J. N., Roesli, C., Kaspar, M., Villa, A. & Neri, D. The extra-domain a of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 67, 10948-10957 (2007).
15. Hemmerle, T. et al. The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. Br. J. Cancer 109, 1206-1213 (2013).
16. Steiner, M. & Neri, D. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends. Clin. Cancer Res. 17, 6406-6416 (2011).
17. Kaplan, R. N., Rafii, S. & Lyden, D. Preparing the "soil": the premetastatic niche. Cancer Res. 66, 11089-11093 (2006).
18. Sceneay, J., Smyth, M. J. & Moller, A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 32, 449-464 (2013).
19. Doerner, A. M. & Zuraw, B. L. TGF-b1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1b but not abrogated by corticosteroids. Respir. Res. 10, 100 (2009).
20. Zhou, F. et al. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-b signalling. Nat. Commun. 5, 3388 (2014).
21. Barkan, D., Green, J. E. & Chambers, A. F. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 46, 1181-1188 (2010).
22. Van Obberghen-Schilling, E. et al. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int. J. Dev. Biol. 55, 511-525 (2011).
23. von Au, A. et al. Circulating fibronectin controls tumor growth. Neoplasia 15, 925-938 (2013).
24. Sipkins, D. A. et al. Detection of tumor angiogenesis in vivo by avb3-targeted magnetic resonance imaging. Nat. Med. 4, 623-626 (1998).
25. Serres, S. et al. Molecular MRI enables early and sensitive detection of brain metastases. Proc. Natl Acad. Sci. USA 109, 6674-6679 (2012).
26. Peiris, P. M. et al. Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano 6, 8783-8795 (2012).
27. Tan, M., Wu, X., Jeong, E. K., Chen, Q. & Lu, Z. R. Peptide-targeted nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging. Biomacromolecules 11, 754-761 (2010).
28. Zhou, Z., Wu, X., Kresak, A., Griswold, M. & Lu, Z. R. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. Biomaterials 34, 7683-7693 (2013).
29. Uppal, R. et al. Molecular imaging of fibrin in a breast cancer xenograft mouse model. Invest. Radiol. 47, 553-558 (2012).
30. Zhou, Z. & Lu, Z. R. Dendritic nanoglobules with polyhedral oligomeric silsesquioxane core and their biomedical applications. Nanomedicine (Lond.) 9, 2387-2401 (2014).
31. Simberg, D. et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA 104, 932-936 (2007).
32. Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759-768 (2010).
33. Gargesha, M. et al. Visualization of color anatomy and molecular fluorescence in whole-mouse cryo-imaging. Comput. Med. Imaging Graph. 35, 195-205 (2011).
34. Qutaish, M. Q. et al. Cryo-image analysis of tumor cell migration, invasion, and dispersal in a mouse xenograft model of human glioblastoma multiforme. Mol. Imaging Biol. 14, 572-583 (2012).
35. Wendt, M. K., Taylor, M. A., Schiemann, B. J., Sossey-Alaoui, K. & Schiemann, W. P. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor beta 1 signaling in metastatic breast cancers. Breast Cancer Res. 16, R24 (2014).
36. Morrison, C. D., Parvani, J. G. & Schiemann, W. P. The relevance of the TGF-b paradox to EMT-MET programs. Cancer Lett. 341, 30-40 (2013).
37. Khanna, C. & Hunter, K. Modeling metastasis in vivo. Carcinogenesis 26, 513-523 (2005).
38. Saxena, M. & Christofori, G. Rebuilding cancer metastasis in the mouse. Mol. Oncol. 7, 283-296 (2013).
39. Pulaski, B. A. & Ostrand-Rosenberg, S. Mouse 4T1 breast tumor model Curr. Protoc. Immunol. 39, 20.22.21-20.22.16 (2001).
40. Burden-Gulley, S. M. et al. Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid threedimensional detail. Cancer Res. 71, 5932-5940 (2011).
41. Bushberg, J. T. & Boone, J. M. The Essential Physics of Medical Imaging 3rd edn (Wolters Kluwer Health, 2011).
42. Song, X. M. et al. Automated region detection based on the contrast-to-noise ratio in near-infrared tomography. Appl. Opt. 43, 1053-1062 (2004).
43. Chakraborty, D. P. Handbook of Medical Imaging 1, 771-796 (2000).
44. Kennecke, H. et al. Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28, 3271-3277 (2010).
45. Chekhun, S., Bezdenezhnykh, N., Shvets, J. & Lukianova, N. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Exp. Oncol. 35, 174-179 (2013).
46. Pilch, J. et al. Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc. Natl Acad. Sci. USA 103, 2800-2804 (2006).
47. Langley, R. R. & Fidler, I. J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev. 28, 297-321 (2007).
48. Fidler, I. J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458 (2003).
49. Coleman, R. E. & Rubens, R. D. The clinical course of bone metastases from breast-cancer. Br. J. Cancer 55, 61-66 (1987).
50. Fernandez-Garcia, B. et al. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology 64, 512-522 (2014).
51. Parvani, J. G., Gujrati, M. D., Mack, M. A., Schiemann, W. P. & Lu, Z.-R. Silencing b3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer. Cancer Res. 75, 2316-2325 (2015).
52. Thomsen, H. S. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur. Radiol. 16, 2619-2621 (2006).
53. Kawamoto, T. Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch. Histol. Cytol. 66, 123-143 (2003).